These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3900023)

  • 1. Effect of beta-lactamase induction on susceptibility to cephalosporins in Enterobacter cloacae and Serratia marcescens.
    Okonogi K; Sugiura A; Kuno M; Higashide E; Kondo M; Imada A
    J Antimicrob Chemother; 1985 Jul; 16(1):31-42. PubMed ID: 3900023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of ceftibuten to induce the class-I beta-lactamases of Enterobacter cloacae, Serratia marcescens, and Enterobacter aerogenes.
    Papanicolaou GA; Medeiros AA
    Diagn Microbiol Infect Dis; 1991; 14(1):85-7. PubMed ID: 2013214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria.
    Rogers DT; Russell AD
    J Appl Bacteriol; 1980 Aug; 49(1):111-8. PubMed ID: 6776086
    [No Abstract]   [Full Text] [Related]  

  • 5. Inactivation of cephalosporins by beta-lactamases of gram-negative rods.
    Bauernfeind A; Petermüller C; Jungwirth R
    Infection; 1983; 11 Suppl 1():S39-43. PubMed ID: 6339417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives.
    Kojo H; Shigi Y; Nishida M
    J Antibiot (Tokyo); 1980 Mar; 33(3):317-21. PubMed ID: 6247313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiologic study on the prevalence of Enterobacter, Serratia and Pseudomonas strains, producers of cefoxitin-inducible beta-lactamases].
    Marone P; Concia E; Perversi L; Cruciani M
    Boll Ist Sieroter Milan; 1986; 65(5):368-73. PubMed ID: 3103651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
    Cullmann W; Dick W
    Immun Infekt; 1984 Feb; 12(1):29-34. PubMed ID: 6335880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-lactamase activity and cross-resistance to different cephalosporins of in vitro selected cefamandole-resistant variants of Enterobacter cloacae.
    Vuye A
    J Pharm Belg; 1982; 37(4):267-72. PubMed ID: 6982969
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae.
    Minami S; Yotsuji A; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Sep; 18(3):382-5. PubMed ID: 6968541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.
    Seeberg AH; Tolxdorff-Neutzling RM; Wiedemann B
    Antimicrob Agents Chemother; 1983 Jun; 23(6):918-25. PubMed ID: 6351733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for nonspecific induction of beta-lactamase in overproducing variants of Enterobacter cloacae and Citrobacter freundii.
    Cullmann W; Dick W
    Eur J Clin Microbiol; 1985 Feb; 4(1):34-40. PubMed ID: 3872794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.
    Gootz TD; Sanders CC; Goering RV
    J Infect Dis; 1982 Jul; 146(1):34-42. PubMed ID: 6979593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
    Binfiglio G; Stefani S; Nicoletti G
    Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.
    Tzouvelekis LS; Prinarakis EE; Gazouli M; Miriagou V; Tzelepi E; Legakis NJ
    Chemotherapy; 1996; 42(5):324-8. PubMed ID: 8874970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC; Shlaes DM
    J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of glycine enhancement with cefoxitin induction of class 1 beta-lactamase production in Enterobacter cloacae ATCC 13047.
    Gatus BJ; Bell SM; Jimenez AS
    J Antimicrob Chemother; 1988 Feb; 21(2):163-70. PubMed ID: 3258859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin.
    Stobberingh EE
    J Antimicrob Chemother; 1988 Jan; 21(1):9-16. PubMed ID: 3128523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp.
    Lindh E; Dornbusch K; Jalakas K; Forsgren A
    APMIS; 1990 May; 98(5):462-70. PubMed ID: 2162681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.